Cancer Genetics misses by $0.01, misses on revenue

|About: Cancer Genetics, Inc. (CGIX)|By:, SA News Editor

Cancer Genetics (CGIX): Q4 EPS of -$0.37 misses by $0.01.

Revenue of $1.85M (+72.9% Y/Y) misses by $0.1M.